The Management Committee of the International Pharmaceutical Regulators Forum (IPRF) met in Jacksonville, Florida, US, on 7 and 8 December 2015. Within the two and a half years after its establishment

The 2nd meeting of the International Generic Drug Regulators Programme (IGDRP) was held in Seoul, South Korea from 4-5 November 2015, with resolution of barriers to progress work-sharing and

The IGDRP Biowaivers working group was formed in May 2013 with the objective of establishing a common set of conditions for the granting of biowaivers as well as the expansion of the application of

The IGDRP ASMF/DMF working group was formed in May 2013 to foster international collaboration and worksharing in the area of evaluations for ASMFs/DMFs during the review of a generic drug product.

The Management Committee of the International Pharmaceutical Regulators Forum (IPRF) met in Fukuoka on 8 and 9 June 2015.  It was the fourth meeting after its establishment in 2013.  

The International Generic Drug Regulators Programme (IGDRP) was formed following progression from its 3-year Pilot phase and continues to promote collaboration and convergence in generic drug

The Management Committee of the International Pharmaceutical Regulators Forum (IPRF) met in Minneapolis, MN, US, on 2 and 3 June 2014. It was the second meeting of this group, following on the work

The Management Committee of the International Pharmaceutical Regulators Forum (IPRF) met in Minneapolis, MN, US, on 2 and 3 June 2014.    It was the second meeting of this group,

The International Pharmaceutical Regulators Forum (IPRF) met in Osaka, Japan, on 11 and 12 November 2013, in connection with the ICH Steering Committee meeting.   It was the

Five years after it met for the first time in June 2008, the Regulators Forum decided to reinforce its role on international cooperation activities between pharmaceutical regulators as the